JESIKA MCKENZIE: Open Payments
NPI 1427634997 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$34,804 in 75 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $994 · 2025 $34,804
Speaker / faculty: $24,192Consulting: $6,188Travel & lodging: $2,395Food & beverage: $2,029
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 42 | $33,544 |
| ACADIA Pharmaceuticals Inc | 20 | $590 |
| E.R. Squibb & Sons, L.L.C. | 5 | $178 |
| Otsuka America Pharmaceutical, Inc. | 3 | $157 |
| Alpha Cognition USA, Inc. | 1 | $144 |
| Alkermes, Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 3 | $66 |
Products named: INGREZZA, NUPLAZID, COBENFY, REXULTI, Zunveyl, LYBALVI, AUSTEDO XR.
Industry payments across AZ — which companies pay providers there.
